Sponsored Links
| Novartis Obtains CHMP Positive Opinion For Its Investigational Pre-pandemic Influenza Vaccine Aflunov® To Help Protect Against (H5N1) |
 |
 |
 |
| Medical News - Bird Flu | |||
|
Novartis announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Aflunov®, an investigational pre-pandemic avian influenza vaccine. The CHMP is endorsing the approval of Aflunov for active immunization against H5N1 subtype of Influenza A virus in adults 18 years of age and older... Read more: Bird Flu / Avian Flu News From Medical News Today
|